Baptist Health Herbert Wertheim Cancer Institute at ISLB 2026

Nov 7–9, 2026 Madrid, Spain ~700 attendees Website

Baptist Health Herbert Wertheim Cancer Institute brings 2 presentations to ISLB 2026 in Madrid. Its work centres on building liquid biopsy into clinical trial design and lung cancer care. One topic is repeated plasma profiling in KRAS-mutant non-small cell lung cancer to plan the next line of treatment.

OrganizationISLB 2026 Attendance
baptisthealth.net
Hospitals & cancer centres
Cancer center of Baptist Health South Florida in Miami, named Miami Cancer Institute until 2026.
Talk
Sun Nov 8
5:30pm–6:30pm
Industry
Mon Nov 9
8:00am–9:00am
Part of From Plasma to Practice: Longitudinal Insights for Breast and Lung Cancer
From KRAS Variant to Next Line: Longitudinal Profiling and Future Therapeutic Sequencing in NSCLC
Industry hosted by Guardant Health
Clinical use · ctDNA & MRD
Session
Mon Nov 9
10:00am–11:30am
Preferred Oral Abstract Session

Explore the full ISLB 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ISLB 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Baptist Health Herbert Wertheim Cancer Institute

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the International Society of Liquid Biopsy (ISLB). Submit a correction